Samsung Bioepis’ Trastuzumab Prequalified By WHO
Ontruzant Is First Ever Biosimilar Prequalified By Organization
Executive Summary
Samsung Bioepis’ Ontruzant trastuzumab biosimilar has become the first biosimilar to be prequalified by the World Health Organization.